PREVIEW: CVS Health Corp (CVS) earnings due 09/Feb at 11:40GMT/06:40EST
CVS Health Corp (CVS) Q4 2021 (USD): EPS (exp. 1.93/0.93 GAAP), Revenue (exp. 75.67bln)
REVENUE SEGMENTS:
- Health Care Benefits: (exp. 20.64bln)
- Pharmacy Services Segment: (exp. 39.17bln)
- Retail/ Long Term Care: (exp. 26.42bln)
DIVIDEND:
- Qtrly Dividend: (exp. 0.50)
- FY Dividend: (exp. 2.00)
EPS GUIDANCE:
- Q1 2022 EPS View: (exp. 2.12/1.76 GAAP)
- FY 2022 EPS View: (exp. 8.28/6.94 GAAP)
REVENUE GUIDANCE:
- Q1 2022 Revenue View: (exp. 74.32bln)
- FY 2022 Revenue View: (exp. 307.62bln)
INDEX WEIGHT:
- 0.4% SPX weight
- Sector/Industry: Health Care/Health Care Providers & Services
BROKER RATING:
- Avg Rating: 'Buy'
- Avg Price Target: USD 113.41
- Price Target Changes (last 30 days): 17 upward vs 0 downward
08 Feb 2022 - 17:00- - Source: Newswires
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts